Asian Spectator


The Times

.

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media OutReach News...

Infocus International Announces New Online Training on Renewable Energy Power Purchase Agreements

Singapore, Jun 9, 2021 - (ACN Newswire) - Infocus International Group has announced a brand new online training - Renewable Energy Power Purchase Agreements (RE PPAs) and it will be commenc...

Trina Solar provides 167MW of PV modules to Europe's largest P...

CHANGZHOU, China, Aug. 10, 2018 /PRNewswire-AsiaNet/ -- On August 9, Trina Solar Limited ("Trina Solar" or the "Company") announced that the photovoltaic (PV) manufacturer will provide 167MW...

Social Enterprise Summit 2022 Gathers Leaders from Civil, Business, Government and Academic Sectors to Bounce Forward Together

HONG KONG SAR - Media OutReach - 24 November 2022 - The 15th Social Enterprise Summit (SES 2022) International Symposium kicks off today at Hong Kong Convention and Exhibition Centre. Held ...

MXP proposes six breakthrough solutions for Vietnam's private ...

HANOI, Vietnam, May 7, 2019 /PRNewswire-AsiaNet/ -- MXP (Manufacturing Sportswear JSC.) has proposed six strategic solutions to Vietnam's Government to strengthen Vietnam's private enterpris...

CHEP accredited as a Top Employer in Malaysia

Awarded Top Employer certification in 25 countries and recognised as a Global Top Employer in 2023 SELANGOR, MALAYSIA - Media OutReach - 20 February 2023 - CHEP, a global leader in suppl...

Opening of Zuunbayan-Khangi railway set to deliver major boost...

ULAANBAATAR, Mongolia, November, 25, 2022, /PRNewswire-AsiaNet/-- The Prime Minister of Mongolia, L. Oyun-Erdene, has today opened a major new rail link which will provide a significant boo...

Director-General of Investment Promotion visits London and Milan to promote Hong Kong's latest business advantages

HONG KONG, Jan 14, 2019 - (ACN Newswire) - The Director-General of Investment Promotion, Mr Stephen Phillips, today (January 14) started his visits to London in the United Kingdom and Milan...

Nexen Tire Successfully Completes 2018 PURPLE SUMMIT Mancheste...

SEOUL, South Korea, April 23, 2018 /PRNewswire-AsiaNet/ -- - Nexen Tire builds stronger ties with worldwide partners by successfully presenting its third PURPLE SUMMIT, the company's annual ...

Hitachi to Provide CNAO with Proton Therapy System

TOKYO, Dec 6, 2019 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.

image

Centro Nazionale di Adroterapia Oncologica (National Center for Oncological Hadrontherapy for the treatment of tumors)

In the comprehensive public tender process, Hitachi has been selected to provide proton therapy systems with the latest technologies including advanced scanning technology to irradiate even tumors with complex shapes with high precision.

The agreement includes multiyear service and maintenance of the system and this will be the 1st Hitachi Proton Therapy System to be installed in Italy and the 2nd in Europe.

CNAO, located in Pavia (near Milan), Italy, is a world's leading clinical center on particle cancer therapy and the first national hadrontherapy center in Italy. CNAO was established and is operated by the CNAO Foundation, a non-profit organization fully funded by the Italian government. CNAO has started cancer treatment for proton therapy since 2011 and heavy ion therapy since 2012, and it will develop a new proton therapy facility to enhance further research and cancer treatment.

Hitachi has been proactively promoting particle therapy system business worldwide, supplying world-class facilities with its highly reliable and proven particle therapy systems, which have treated more than 60,000 patients. Hitachi will provide system and services, including single room solution in realizing installation in urban limited areas and hybrid system combined with capability of generating both proton and heavy-ion in one accelerator, to meet all customer needs.

Hitachi will contribute to the improvement of people's quality of life and social values through the global expansion of its particle therapy system business.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is focusing on Social Innovation Business combining its operational technology, information technology and products. The company's consolidated revenues for fiscal 2018 (ended March 31, 2019) totaled 9,480.6 billion yen ($85.4 billion), and the company has approximately 296,000 employees worldwide. Hitachi delivers digital solutions utilizing Lumada in five sectors including Mobility, Smart Life, Industry, Energy and IT, to increase our customer's social, environmental and economic value. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girişStreamEastStreamEastjojobetcialis 20 mg fiyat